Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

MLA

Toshikazu Tanaka, et al. “Aberrant N-Glycosylation Profile of Serum Immunoglobulins Is a Diagnostic Biomarker of Urothelial Carcinomas.” International Journal of Molecular Sciences, vol. 18, no. 12, Dec. 2017, p. 2632. EBSCOhost, https://doi.org/10.3390/ijms18122632.

APA

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, & Chikara Ohyama. (2017). Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas. International Journal of Molecular Sciences, 18(12), 2632. https://doi.org/10.3390/ijms18122632

Chicago

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, et al. 2017. “Aberrant N-Glycosylation Profile of Serum Immunoglobulins Is a Diagnostic Biomarker of Urothelial Carcinomas.” International Journal of Molecular Sciences 18 (12): 2632. doi:10.3390/ijms18122632.